Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Ron Luhmann who wrote (9596)	7/1/1998 2:56:00 PM
From: Ron Luhmann	Respond to of 14328

don't ya just love an active board...I'm sure we're on the SI "Hot List"...which means nothing! ..hehe.. Go TRIBY !!

To: Ron Luhmann who wrote (9596)	7/1/1998 3:00:00 PM
From: dowman	Read Replies (2) \| Respond to of 14328

Care to "prove" me wrong on the HIV2 issue? And as to Abbott, they also will be testing their next generation product with the CDC. And by the way, the CDC does not give "approval". And as to the innuendo that Abbott is selling Trinitys product, I would doubt very highly that is the case. And here is the point about an HIV2 test. Once a combination HIV1 &2 test is available, no one will take the liability risk of using a test that only tests for HIV1, such as the current product at the FDA.